ArticlemAbs

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells

Omar S Qureshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.